JDBIOTECH Fascioliasis IgG Rapid Test

Taipei City, Taiwan

In 1996, the company was founded in Taipei. With more than 15 years of experience in the IVD market, our growth has been driven by the development of new products and the exploration of new market niches and opportunities. In 2005, we received our first GMP and ISO 13485 approval in Jinan, China. In 2023, we have been approved ISO13485:2016, Scope with :Design and Development, Manufacture and Distribution of IVD test kits for the diagnosis of Infectious disease, Disease Status, Sexually transmissible agents, Pregnancy Testing, Fertility testing including Near Patient/Point of Care and home use. Our Mission: JD is dedicated to making advanced Point-of-Care solutions accessible to patients worldwide through innovative products. Goal: Our goal is to research, develop, and manufacture IVD Point-of-Care solutions with the objective of enhancing the quality of patient care and delivering rapid diagnostics that combine high quality, affordability, and flexibility.